These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 38360740)
1. TC14012 enhances the anti-fibrosis effects of UC-MSCs on the liver by reducing collagen accumulation and ameliorating inflammation. Ding F; Liu Y; Li J; Wei X; Zhao J; Liu X; Zhang L Stem Cell Res Ther; 2024 Feb; 15(1):44. PubMed ID: 38360740 [TBL] [Abstract][Full Text] [Related]
2. Human umbilical cord-derived mesenchymal stem cells attenuate hepatic stellate cells activation and liver fibrosis. Shi X; Zhang K; Qi Q; Zhou W; Yu F; Zhang Y Mol Biol Rep; 2024 Jun; 51(1):734. PubMed ID: 38874773 [TBL] [Abstract][Full Text] [Related]
3. Human umbilical cord-derived mesenchymal stromal cells alleviate liver cirrhosis through the Hippo/YAP/Id1 pathway and macrophage-dependent mechanism. Yao L; Hu X; Yuan M; Liu P; Zhang Q; Wang Z; Chen P; Xiong Z; Wu L; Dai K; Jiang Y Int Immunopharmacol; 2023 Oct; 123():110456. PubMed ID: 37494836 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of CXCL9-overexpressing human umbilical cord mesenchymal stem cells on liver fibrosis in rats. Li Y; Dong J; Zhou Y; Ye X; Cai Z; Zhang X; Shen L; Zhang M; Zhang W; Cai J Biochem Biophys Res Commun; 2021 Dec; 584():87-94. PubMed ID: 34775285 [TBL] [Abstract][Full Text] [Related]
5. Preconditioning of umbilical cord-derived mesenchymal stem cells by rapamycin increases cell migration and ameliorates liver ischaemia/reperfusion injury in mice via the CXCR4/CXCL12 axis. Zheng J; Li H; He L; Huang Y; Cai J; Chen L; Zhou C; Fu H; Lu T; Zhang Y; Yao J; Yang Y Cell Prolif; 2019 Mar; 52(2):e12546. PubMed ID: 30537044 [TBL] [Abstract][Full Text] [Related]
6. Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils. Xie Y; Yao J; Yan M; Lin Y; Wei J; Wang H; Mao Y; Liu P; Li X J Transl Med; 2023 Nov; 21(1):832. PubMed ID: 37980535 [TBL] [Abstract][Full Text] [Related]
7. Anti-fibrotic effect of intravenous umbilical cord-derived mesenchymal stem cells (UC-MSCs) injection in experimental rats induced liver fibrosis. Sungkar T; Putra A; Lindarto D; Juwita Sembiring R Med Glas (Zenica); 2021 Feb; 18(1):62-69. PubMed ID: 33078915 [TBL] [Abstract][Full Text] [Related]
9. Human Umbilical Cord Mesenchymal Stem Cells Ameliorate Hepatic Stellate Cell Activation and Liver Fibrosis by Upregulating MicroRNA-455-3p through Suppression of p21-Activated Kinase-2. Zhou Q; Gu T; Zhang Y; Li H; Zhuansun X; Xu S; Kuang Y Biomed Res Int; 2021; 2021():6685605. PubMed ID: 33708992 [TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936 [TBL] [Abstract][Full Text] [Related]
11. Gain of CXCR7 function with mesenchymal stem cell therapy ameliorates experimental arthritis via enhancing tissue regeneration and immunomodulation. Wei ST; Huang YC; Chiang JY; Lin CC; Lin YJ; Shyu WC; Chen HC; Hsieh CH Stem Cell Res Ther; 2021 May; 12(1):314. PubMed ID: 34051857 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway. Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205 [TBL] [Abstract][Full Text] [Related]
14. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis. Yuan M; Yao L; Chen P; Wang Z; Liu P; Xiong Z; Hu X; Li L; Jiang Y Int Immunopharmacol; 2023 Dec; 125(Pt A):111134. PubMed ID: 37918086 [TBL] [Abstract][Full Text] [Related]
15. [Umbilical cord mesenchymal stem cells and their association with liver fibrosis]. Tuo L; Zeng WZ; Xue HL; Wu XL Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):65-68. PubMed ID: 28297787 [TBL] [Abstract][Full Text] [Related]
16. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. Ding BS; Cao Z; Lis R; Nolan DJ; Guo P; Simons M; Penfold ME; Shido K; Rabbany SY; Rafii S Nature; 2014 Jan; 505(7481):97-102. PubMed ID: 24256728 [TBL] [Abstract][Full Text] [Related]
18. Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis. Shen C; Lie P; Miao T; Yu M; Lu Q; Feng T; Li J; Zu T; Liu X; Li H Mol Med Rep; 2015 Jul; 12(1):20-30. PubMed ID: 25739039 [TBL] [Abstract][Full Text] [Related]
19. Extracellular superoxide dismutase increased the therapeutic potential of human mesenchymal stromal cells in radiation pulmonary fibrosis. Wei L; Zhang J; Yang ZL; You H Cytotherapy; 2017 May; 19(5):586-602. PubMed ID: 28314668 [TBL] [Abstract][Full Text] [Related]
20. Corticosterone mediates the inhibitory effect of restraint stress on the migration of mesenchymal stem cell to carbon tetrachloride-induced fibrotic liver by downregulating CXCR4/7 expression. Zhang S; Lv C; Yang X; Han Z; Zhang S; Zhang J; Zong C; Gao L; Li L; Zhao Q; Li R; Yang Y; Yu F; Li X; Zhang P; Wei L Stem Cells Dev; 2015 Mar; 24(5):587-96. PubMed ID: 25268050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]